SCHEMBL207570

SCHEMBL207570

COC(=O)c1ccc(-c2cc(Cl)c([C@H](C3CCC(O[Si](C(C)C)(C(C)C)C(C)C)CC3)C3CCNC3=O)c(Cl)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 2/20 0.35
RHEB Q15382 1/20 0.35
PSD A5PKW4 1/20 0.34
ALDH1A1 P00352 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
KDM5B Q9UGL1 1/20 0.32
SLC6A3 Q01959 2/20 0.32
IP6K1 Q92551 1/20 0.32
KDM4E B2RXH2 2/20 0.31
MAPT P10636 1/20 0.31
GSK3B P49841 1/20 0.31
PLAT P00750 1/20 0.31
CNR1 P21554 1/20 0.31
CHKA P35790 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
PTGES O14684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4060990 0.91 SRD5A2 (0.32) MAP2K4
SCHEMBL208541 0.91 SRD5A2 (0.32) MAP2K4
SCHEMBL208949 0.89 RHEB (0.36) MAP2K4RHEBPSDALDH1A1L3MBTL1
SCHEMBL1092147 0.85 PSD (0.35) MAP2K4RHEBPSDALDH1A1L3MBTL1
SCHEMBL208481 0.85 SLC6A3 (0.41) MAP2K4RHEBALDH1A1L3MBTL1SLC6A3
SCHEMBL474994 0.84 KDM4E (0.35) MAP2K4RHEBALDH1A1L3MBTL1SLC6A3
SCHEMBL4066975 0.84 CSF1R (0.37) MAP2K4RHEBALDH1A1SLC6A3KDM4E
SCHEMBL210505 0.84 CSF1R (0.37) MAP2K4RHEBALDH1A1SLC6A3KDM4E
SCHEMBL208452 0.81 PDE4D (0.35) SLC6A3SLC6A2SLC6A4
SCHEMBL1093033 0.81 PSD (0.34) MAP2K4RHEBPSDALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-7816349-B2 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2010-10-19 US disclosed
EP-2029529-B1 SUBSTITUTED PYRROLIDINONES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2010-07-07 EP disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed
US-20090069326-A1 SUBSTITUTED PYRROLIDINONES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069326-A1 SUBSTITUTED PYRROLIDINONES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD3B1 MAP2K4 1878/4885RHEB 1663/4885PSD 351/4885
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 MAP2K4 2437/4885RHEB 2359/4885PSD 518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.